Catalyst Wire Dossier Catalyst Wire Dossier

Eversense CGM

continuous glucose monitor · Senseonics
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Eversense CGM, covering 2017-05-22 to 2025-06-12. Get the full timeline:

Most recent: Clinical Trial Update: Post Approval Study of the Eversense® Continuous Glucose Monitoring [NA]

See pricing